Sio Capital Management, LLC 13D and 13G filings for Salarius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 4:05 pm Sale |
2021-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX |
Sio Capital Management, LLC | 6,771 3.000% |
-1,515 (-18.28%) |
Filing |
| 2021-02-16 1:03 pm Purchase |
2020-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX |
Sio Capital Management, LLC | 8,286 8.350% |
8,286 (New Position) |
Filing |